Significance of lymphatic invasion and proliferation on regional lymph node metastasis in renal cell carcinoma

American Journal of Clinical Pathology

Volumn 128, Issue 2, 2007, Pages 198-207

  Ishikawa, Yukio ^a   Aida, Shinsuke ^b   Tamai, Seiichi ^b   Akasaka, Yoshikiyo ^a   Kiguchi, Hideko ^c   Akishima Fukasawa, Yuri ^d   Hayakawa, Masamichi ^e   Soh, Shigehiro ^e   Ito, Kinji ^a   Kimura Matsumoto, Masayo ^a   Ishiguro, Shigeki ^a   Nishimura, Chiaki ^a   Kamata, Itaru ^f   Shimokawa, Reiko ^g   Ishii, Toshiharu ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c Saiseikai Kawanaga ken Hospital   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOHO UNIVERSITY   (Japan)

^g Omori Red Cross Hospital   (Japan)

Author keywords

D2 40; Lymph node metastasis; Lymphatic density; Lymphatic invasion; Renal cell carcinoma; Vascular endothelial growth factor; VEGF C

Indexed keywords

VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CARCINOMA, RENAL CELL; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 34547896286     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/0FT8WTDKREFHHP4P     Document Type: Article

References (41)

1. Mejean A, Oudard S, Thiounn N. Prognostic factors of renal cell carcinoma. J Urol. 2003;169:821-827.
2. McNichols DW, Segura JW, DeWeed JH. Renal cell carcinoma: long-term survival and late recurrence. J Urol. 1981;126:17-23.
3. Selli C, Hinshaw WM, Woodard BH, et al. Stratification of risk factors in renal cell carcinoma. Cancer. 1983;52:899-903.
4. Hermanek P, Schrott KM. Evaluation of the tumor, nodes and metastases classification of renal cell carcinoma. J Urol. 1990;144:238-241.
5. Urological tumours. In: Sobin LH, Wittekind CH, for the International Union Against Cancer [UICC], eds. TNM Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002:179-206.
6. Giuliani L, Giberti C, Martorana G, et al. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol. 1990;143:468-474.
7. Ficarra V, Righetti R, Pilloni S, et al. Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases. Eur Urol. 2002;41:190-198.
8. Phillips CK, Taneja SS. The role of lymphadenectomy in the surgical management of renal cell carcinoma. Urol Oncol. 2004;22:214-224.
9. Kim HL, Lam JS, Belldegrun AS. The role of lymphadenectomy in renal cell carcinoma. Curr Urol Rep. 2004;5:25-29.
10. Fuselier HA, Guice SL, Brannan W, et al. Renal cell carcinoma: the Ochsner Medical Institution experience (1945-1978). J Urol. 1983;130:445-448.
11. Blom JHM, van Poppel H, Marechal JM, et al. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. Eur Urol. 1999;36:570-575.
12. Minervini A, Lilas L, Morelli G, et al. Regional lymph node dissection in the treatment of renal cell carcinomas: is it useful in patients with no suspected adenopathy before or during surgery? BJU Int. 2001;88:169-172.
13. Pantuck AJ, Zisman A, Dorey F, et al. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol. 2003;169:2076-2083.
14. Giberti C, Oneto F, Martorana G, et al. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases. Eur Urol. 1997;31:40-48.
15. Schafhauser W, Ebert A, Brod J, et al. Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy. Anticancer Res. 1999;19:1573-1578.
16. Terrone C, Guercio S, De Luca S, et al. The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int. 2003;91:37-40.
17. Cuttino JT Jr, Clark RL, Jennette JC. Microradiographic demonstration of human intrarenal microlymphatic pathways. Urol Radiol. 1989;11:83-87.
18. Akishima Y, Ito K, Zhang L, et al. Immunohistochemical detection of human small lymphatic vessels under normal and pathological conditions using the LYVE-1 antibody. Virchows Arch. 2004;444:153-157.
19. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434-440.
20. Ishikawa Y, Akasaka Y, Kiguchi H, et al. The human renal lymphatics under normal and pathological conditions. Histopathology. 2006;49:265-273.
21. Eble JN, Sauter G, Epstein JI, et al. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004. World Health Organization Classification of Tumours.
22. Mostofi FK, Davis CJ. Histological Typing of Kidney Tumours. 2nd ed. Berlin, Germany: Springer-Verlag; 1998. World Health Organization International Classification of Tumours.
23. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655-663.
24. Tsukamoto T, Kumamoto Y, Miyao N, et al. Regional lymph node metastasis in renal cell carcinoma: incidence, distribution and its relation to other pathological findings. Eur Urol. 1990;18:88-93.
25. Kanamaru H, Mori H, Sakai M, et al. Histologic characteristics of renal cell carcinoma with lymph node metastasis. Int J Urol. 1997;4:451-455.
26. Medeiros LJ, Gelb AB, Weiss LM. Renal cell carcinoma: prognostic significance of morphologic parameters in 121 cases. Cancer. 1998;61:1639-1651.
27. Minardi D, Lucarini G, Mazzucchelli R, et al. Prognostic role of Fuhrman grade and vascular endothelial growth factor in pTla clear cell carcinoma in partial nephrectomy specimens. J Urol. 2005;174:1208-1212.
28. Usubutun A, Ayhan A, Uygur MC, et al. Prognostic factors in renal cell carcinoma. J Exp Clin Cancer Res. 1998;17:77-81.
29. Lang H, Lindner V, Letourneux H, et al. Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up. Eur Urol. 2004;46:331-335.
30. Ishimura T, Sakai I, Hara I, et al. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery. Int J Urol. 2004;11:264-268.
31. Hoehn W, Hermanek P. Invasion of veins in renal cell carcinoma: frequency, correlation and prognosis. Eur Urol. 1983;9:276-280.
32. Holmes MJ, O'Morchoe PJ, O'Morchoe CCC. Morphology of the intrarenal lymphatic system: capsular and hilar communications. Am J Anat. 1977;149:333-351.
33. Swartz MA, Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. Microsc Res Tech. 2001;55:92-99.
34. Beasley NJ, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 2002;62:1315-1320.
35. Tsuchiya N, Sato K, Akao T, et al. Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma. Tohoku J Exp Med. 2001;195:101-113.
36. Schoppmann SF, Bimer P, Stockl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002;161:947-956.
37. Mrstik CH, Salamon J, Weber R, et al. Microscopic venous infiltration as predictor of relapse in renal cell carcinoma. J Urol. 1992;148:271-274.
38. Lang H, Lindner V, Saussine C, et al. Microscopic venous invasion: a prognostic factor in renal cell carcinoma. Eur Urol. 2000;38:600-605.
39. Serinc M, Kirkali Z, Yorukoglu K, et al. Prognostic significance of microvascular invasion in localized renal cell carcinoma. Eur Urol. 2000;38:728-733.
40. Goncalves PD, Srougi M, Dall'Oglio MH, et al. Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter. J Urol. 2004;172:470-474.
41. Bonsib SM. Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell carcinoma: a study of 40 cases. Mod Pathol. 2006;19:746-753.